Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]SymBio Pharmaceuticals"
Count: 23
Selected: 0
NCT IDTitle
NCT04706923A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection
NCT00794638A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma
NCT04542252Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects
NCT03604679SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors
NCT03372837Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma
NCT00389051A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-cell Non-Hodgkin's Lymphoma
NCT04354402Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL
NCT03900377Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma
NCT03495167Study of SyB C-1101 in Patients With Myelodysplastic Syndrome
NCT03005899Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain
NCT02000154Long Term Safety Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
NCT02002936Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
NCT02042911Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia
NCT02014051Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
NCT01700335Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
NCT02783547Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome
NCT01718691Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
NCT01849848Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma
NCT01700140Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
NCT01118845Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT01179490Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma
NCT00612183Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
NCT01650051Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)